(Reuters) - Swiss drugmaker Actelion Ltd has initiated preliminary discussions with U.S. biotech company ZS Pharma Inc, marking the latest bout of deal-making in a healthcare sector that has seen a wave of recent takeovers.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49c1c05e/sc/7/l/0L0Sreuters0N0Carticle0C20A150C0A90C110Cus0Ezs0Epharma0Em0Ea0Eactelion0EidUSKCN0ARA2HU20A150A9110DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
No comments:
Post a Comment